We are live on ! Find out more
ELOX

Eloxx Pharmaceuticals, Inc. Common Stock
ELOX

Delisted

ELOX was delisted on the 13th of October, 2023.

Back to rankings

1 hedge funds and large institutions have $62 invested in Eloxx Pharmaceuticals, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% less funds holding

Funds holding: 4 → 1 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

100% less capital invested

Capital invested by funds: $109K → $62 (-$109K)

Holders
1
Holders Change
-3
Holders Change %
-75%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OPTFSNA
Old Point Trust & Financial Services N A
Virginia
+$62

Top Sellers

Rank Fund Capital Flow
1
MMH
Menora Mivtachim Holdings
Israel
-$62.8K
2
AS
Altshuler Shaham
Israel
-$30.1K
3
CI
Clal Insurance
Israel
-$16K
4
MAM
Meeder Asset Management
Ohio
-$18
Name Holding Trade Value Shares
Change 		Change in
Stake
OPTFSNA
1
Old Point Trust & Financial Services N A
Virginia
$62 +$62 +62 New
MMH
2
Menora Mivtachim Holdings
Israel
– -$62.8K -52,355 Closed
AS
3
Altshuler Shaham
Israel
– -$30.1K -25,123 Closed
CI
4
Clal Insurance
Israel
– -$16K -13,526 Closed
MAM
5
Meeder Asset Management
Ohio
– -$18 -15 Closed

ELOX Hedge Fund Activity: Q1 2024 in Review

1 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) for Q1 2024, worth a combined $62 — down 100% from $109K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ELOX and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Old Point Trust & Financial Services N A, opening a new position worth an estimated $62. The largest seller was Menora Mivtachim Holdings, exiting entirely with an estimated $62.8K sold.

  • 1 institutional investor held Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) as of Q1 2024, down from 4 in Q4 2023.
  • Funds reported $62 of Eloxx Pharmaceuticals, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 1 fund opened new Eloxx Pharmaceuticals, Inc. Common Stock positions in Q1 2024 and 4 closed out, a net change of -3 holders.
  • The largest Eloxx Pharmaceuticals, Inc. Common Stock buyer in Q1 2024 was Old Point Trust & Financial Services N A, an estimated $62 added.
  • The largest Eloxx Pharmaceuticals, Inc. Common Stock seller in Q1 2024 was Menora Mivtachim Holdings, an estimated $62.8K sold.

Based on aggregated 13F filings for Q1 2024.